S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
Top-Rated Stocks  
NASDAQ:RCKT

Rocket Pharmaceuticals - RCKT Earnings Date, Estimates & Call Transcripts

$17.13
+0.84 (+5.16%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$16.40
▼
$17.20
50-Day Range
$15.79
▼
$22.60
52-Week Range
$7.57
▼
$23.48
Volume
899,469 shs
Average Volume
861,642 shs
Market Capitalization
$1.36 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.58

Earnings Summary

Upcoming
Earnings Date
May. 4Estimated
Actual EPS
(Feb. 27)
-$0.92 Missed By -$0.10
Consensus EPS
(Feb. 27)
-$0.82
Last Year's Q1 EPS
(2/24/2022)
-$0.69
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RCKT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RCKT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rocket Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.96)($0.76)($0.85)
Q2 20233($0.96)($0.76)($0.85)
Q3 20233($0.97)($0.76)($0.85)
Q4 20233($0.95)($0.76)($0.84)
FY 202312($3.84)($3.04)($3.38)

RCKT Earnings Date and Information

Rocket Pharmaceuticals last issued its earnings data on February 27th, 2023. The biotechnology company reported ($0.92) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.82) by $0.10. Rocket Pharmaceuticals has generated ($3.29) earnings per share over the last year (($3.29) diluted earnings per share). Earnings for Rocket Pharmaceuticals are expected to grow in the coming year, from ($3.31) to ($2.03) per share. Rocket Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 4th, 2023 based off prior year's report dates.

Rocket Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/4/2023
(Estimated)		        
2/27/2023Q4 2022($0.82)($0.92)($0.10)($0.92)
11/3/2022Q3 2022($0.77)($0.87)($0.10)($0.87)
8/8/2022Q2 2022($0.68)($0.83)($0.15)($0.83)
5/5/2022Q1 2022($0.70)($0.67)+$0.03($0.67)
2/24/2022Q4 2021($0.75)($0.69)+$0.06($0.69)    
11/3/20219/30/2021($0.60)($0.79)($0.19)($0.79)
8/9/20216/30/2021($0.66)($0.55)+$0.11($0.55)    
5/10/20213/31/2021($0.69)($0.65)+$0.04($0.65)
2/25/202112/31/2020($0.52)($1.08)($0.56)($1.08)
11/4/20209/30/2020($0.45)($0.53)($0.08)($0.53)
8/5/20206/30/2020($0.50)($0.45)+$0.05($0.45)
5/6/20203/31/2020($0.48)($0.45)+$0.03($0.45)
3/5/202012/31/2019($0.49)($0.39)+$0.10($0.39)
11/7/2019Q3($0.4920)($0.38)+$0.1120($0.38)
8/7/2019Q2 2019($0.4820)($0.38)+$0.1020($0.38)
5/8/20193/31/2019($0.63)($0.43)+$0.20($0.43)
3/7/201912/31/2018($0.45)($0.66)($0.21)($0.66)
11/7/20189/30/2018($0.43)($0.40)+$0.03($0.40)
8/8/2018Q2 2018($0.3650)($0.40)($0.0350)($0.40)
5/11/2018Q1 2018($0.28)($0.42)($0.14)($0.42)
8/3/2017Q2 2017($0.47)($0.24)+$0.23($0.24)
5/10/2017Q1 2017($0.3930)($0.40)($0.0070)($0.40)
3/16/2017Q4 2016($0.4320)($0.4810)($0.0490)($0.48)
11/9/2016Q3 2016($0.45)($0.41)+$0.04($0.41)
8/10/2016Q2($0.40)($0.33)+$0.07($0.33)
5/11/2016Q1($0.22)($0.38)($0.16)($0.38)
3/23/2016Q4($0.37)($0.13)+$0.24
11/12/2015Q3 2015($1.84)($1.00)+$0.84$7.92
8/6/2015Q2 2015($0.29)($0.26)+$0.03($0.37)
5/15/2015Q1 2015$0.80+$0.80$2.44












Rocket Pharmaceuticals Earnings - Frequently Asked Questions

When is Rocket Pharmaceuticals's earnings date?

Rocket Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 4th, 2023 based off last year's report dates. Learn more on RCKT's earnings history.

Did Rocket Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) missed the analysts' consensus estimate of ($0.82) by $0.10 with a reported earnings per share (EPS) of ($0.92). Learn more on analysts' earnings estimate vs. RCKT's actual earnings.

How much profit does Rocket Pharmaceuticals generate each year?

Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$221.86 million. RCKT has generated -$3.29 earnings per share over the last four quarters.

What is Rocket Pharmaceuticals's EPS forecast for next year?

Rocket Pharmaceuticals's earnings are expected to grow from ($3.31) per share to ($2.03) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:RCKT) was last updated on 3/31/2023 by MarketBeat.com Staff